Updated 08:05 GMT, 20 Nov 2026 SPX 7,175.83 -2.02% NDX 26,517.05 -2.21% VIX 28.44 +15.80% GOLD 3,574.90 -3.00% CL 82.63 -0.70% BTC 61,735.58 -0.27%
NAS100 26,517 −2.21% S&P 7,176 −2.02% GOLD $3,575 −3.00% BTC $61,736 −0.27% VIX 28.44 +15.80% latest tape · as of 08:05 UTC
The Screen · Consumer Cyclical · Residential Construction

PulteGroup logoPulteGroup

PHM · a US exchange · USD · Market cap $24.7B · 6,506 employees

PulteGroup, Inc., through its subsidiaries, engages in the homebuilding business in the United States.

PASS · Titan Ethical · score 91.1
122.52 USD

Price as of 19 Nov 2026Daily close, not a live quote

Screened 2026-11-19 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price122.52 USD at the 19 Nov 2026 close
  • Our value readFair vs our fair value, as of 19 Nov 2026
  • Our regime readMarkup, as of 17 Nov 2026
  • Ethical screenPasses, score 91.1 out of 100
  • OptionsOpen interest leans heavily to calls (put/call 0.64)
  • Last reviewed19 Nov 2026 (1 day ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $90.00 to $126.89, base estimate $110.34 (screen dated 2026-11-19).

Current read
Markup ?
Fair · screened 2026-11-19
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 0.64, read 2026-11-19
  • Ethical passes the values gate
Price122.52 USD
Fair value110.34
Ethical score91.1/100
Value readFairas of 19 Nov 2026
Our investment reviews on this name
2026-10-29Read Markup119.71+2.3% to today ✓Markdown gives way to Markup after a 7% slide in 7 weeks
2026-09-09Read Markdown129.00-5.0% to today ✓Markup gives way to Markdown with volume flow in agreement
2026-08-08Read Markup133.01-7.9% to today Distribution gives way to Markup after a 12% rise in 5 weeks
2026-07-02Read Distribution118.40+3.5% to today First review on file: Distribution with results news in the headlines

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

PulteGroup holds its Markup at $122.52. The statistical read favours the sellers, held for 14 days.

As held on the ledger · 2026-11-19
PhaseMarkup
Quantitative stateThe statistical read favours the sellers, held for 14 days
Price at the screen$122.52
Valuation13.84 trailing · 13.76 forward price to earnings
Values screenPASS · score 91.1
Beta1.18
The Workings

Five Screens: PHM's Results

PASS. All five recorded results clear their limits.

TestFigureLimitStatus
Business activity Permissible Permissible core business Pass
Debt load 12.73% Below 33% Pass
Interest-bearing cash 0.93% Below 33% Pass
Receivables 12.37% Below 49% Pass
Revenue purity 0.26% Below 5% Pass

Definitions, sources and threshold rules: ticker values-screen methodology.

The Ethical Read

Why It Clears, in Plain English

PulteGroup clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 13%, inside the ~33% line, and almost none of its income is interest, so it passes.

Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when PHM's ethical verdict changes

Today PHM passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Fair vs our fair value, as of 19 Nov 2026: it trades above our $110.34 fair value estimate, moderate competitive moat.

Model construction and limits: fair-value methodology.

90.00Conservative110.34Base case126.89Growth case 122.52Price

Fair value range in USD, drawn from the 2026-11-19 screen. The gold marker is the market price at the same screen. The price runs 11.0% above the base estimate.

The Street's Range
100.00Street low 136.00Street average 162.00Street high 122.52Price

Third-party analyst targets: 17 covering, consensus Buy. The average target sits +11% from the screen price.

Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.

Price History & Projections

Where our models see it going: fair-value estimate $110.34, with a range of $90.00 to $126.89, dated to the 2026-11-19 screen.

How our estimate and third-party targets differ.

The Business, in Plain Words
The fundamentals · plain-English read
Forward P/E13.8xreasonably valued
Trailing P/E13.8xreasonably valued
EPS, trailing9.36
EPS, forward9.41
Revenue growth-9.8%revenue is shrinking
Profit margin11.2%thin but positive margins
Return on equity13.9%a solid return on shareholder capital
FCF yield3.42%
Dividend yield0.83%
Debt to equity0.18minimal debt: a conservative balance sheet
Current ratio6.99comfortably covers its short-term bills
Beta1.18moves a little more than the market
Short interest, float0.06%
52-week range107.16 - 144.50
MoatMODERATE
Market cap$24.7B
Employees6,506

Metric definitions and interpretation rules: ticker-page methodology.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-19 Markup $125.01 -3.5% Entry 19

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 3.5% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 14%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (17 analysts) rates it buy, with a mean price target of $132.

2026-11-12 Markup $129.50 -4.8% Entry 18

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 4.8% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 14%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (17 analysts) rates it buy, with a mean price target of $132.

2026-11-05 Markup $135.97 +13.6% Entry 17

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 13.6% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 14%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (17 analysts) rates it buy, with a mean price target of $132.

2026-10-29 Markup · changed $119.71 +5.4% Entry 16

The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 5.4% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 14%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (17 analysts) rates it buy, with a mean price target of $133.

2026-10-22 Markdown $113.55 +0.0% Entry 15

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 14%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (17 analysts) rates it buy, with a mean price target of $135. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-21 Markdown $113.55 +0.0% Entry 14

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 14%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (17 analysts) rates it buy, with a mean price target of $135. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-20 Markdown $113.55 +0.0% Entry 13

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 14%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (17 analysts) rates it buy, with a mean price target of $135. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-19 Markdown $113.55 +0.0% Entry 12

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 14%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (17 analysts) rates it buy, with a mean price target of $136. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-18 Markdown $113.55 +0.0% Entry 11

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 14%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (17 analysts) rates it buy, with a mean price target of $136. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-17 Markdown $113.55 +0.5% Entry 10

The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 0.5% since our last review. Ethical screening: PASS with near-perfect ethical score. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 14%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (17 analysts) rates it buy, with a mean price target of $136. It reported earnings in this window, a natural checkpoint for the thesis.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on PHM

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in PHM's Space

Screened names in the same industry · explore each on its own page.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · PHM
DateInsiderTitleTypeSharesValue
2026-05-08 SNYDER LILA Director 3,339 $391,264
2026-04-29 GRISE CHERYL W Director 1,507 ·
2026-04-29 BLAIR BRYCE Director 1,507 ·
2026-04-29 HAWAUX ANDRE J Director 1,507 ·
2026-04-29 ACTIS-GRANDE KRISTEN Director 1,507 ·
2026-04-29 SCHALL BENJAMIN Director 1,507 ·
2026-04-29 GANNON KRISTIN F Director 1,507 ·
2026-04-29 SNYDER LILA Director 1,507 ·
2026-02-24 HENRY KEVIN A Officer 5,173 $729,574
2026-02-10 GANNON KRISTIN F Director 292 ·

Public filings, recorded as found. The full tape lives at Insider Intelligence.

The Political Ledger · Congressional Disclosures
Disclosures naming PHM
DatePoliticianPartyTypeAmount
2026-09-11 Ro Khanna Democrat buy 15K–50K
2026-09-11 Ro Khanna Democrat buy 15K–50K
2026-09-11 Ro Khanna Democrat buy 15K–50K
2026-09-11 Ro Khanna Democrat buy 15K–50K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $110.90 +12.7% · $1,127 +12.7%
2 months $117.26 +6.6% · $1,066 +6.6%
3 months $127.39 -1.9% $0.26 $983 -1.7%
6 months $115.93 +7.8% $0.52 $1,083 +8.3%
1 year $112.53 +11.1% $1.04 $1,120 +12.0%
2 years $126.49 -1.2% $1.92 $1,003 +0.3%
3 years $86.28 +44.9% $2.72 $1,480 +48.0%
5 years $49.85 +150.8% $3.96 $2,587 +158.7%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever PHM does next, these words stay.

PulteGroup · PHM · Markup · $122.52
Recorded 2026-11-19 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.